NSGO

Nordic Society of Gynecologic Oncology

Publications

All publications
Apexigen and the Nordic Society of Gynaecological Oncology – Clinical Trial Unit Announce Collaborative Phase 2 Study of Sotigalimab (APX005M)

Apexigen and the Nordic Society of Gynaecological Oncology – Clinical Trial...

16 Jun 2021

View
Niraparib in patients with newly diagnosed advanced ovarian BRCAm cancer: a post hoc

Niraparib in patients with newly diagnosed advanced ovarian BRCAm cancer: a post hoc

10 Mar 2021

View
Nordic Society of Gynaecological Oncology - NSGO Annual Meeting 2021,

Nordic Society of Gynaecological Oncology - NSGO Annual Meeting 2021,

26 Feb 2021

View
Overview of NSGO-CTU Trials and responsible Project Managers, 29-12-2020 Participating

Overview of NSGO-CTU Trials and responsible Project Managers, 29-12-2020...

5 Jan 2021

View
NSGO Bylaws - Amendment 6 March 2020 - 1. Name and Domicile

NSGO Bylaws - Amendment 6 March 2020 - 1. Name and Domicile

16 Apr 2020

View
GLOBAL ACADEMY of WOMEN’S CANCER 24/25 APRIL 2020 VIENNA

GLOBAL ACADEMY of WOMEN’S CANCER 24/25 APRIL 2020 VIENNA

6 Dec 2019

View
Trials sponsored by NSGO-CTU, closed for recruitment

Trials sponsored by NSGO-CTU, closed for recruitment

21 Nov 2019

View
Common Terminology Criteria for Adverse Events (CTCAE) - Version 5.0

Common Terminology Criteria for Adverse Events (CTCAE) - Version 5.0

28 Feb 2018

View
Clinical  trials  are,  however,  not  the  sole   function   of  NSGO.  At  least  equally  important  is  our  activity

Clinical  trials  are,  however,  not  the  sole   function   of  NSGO.  At...

22 Sep 2015

View
Appendix 4. - Recommendations for Grading of Acute and Subacute Toxicity ALLERGY

Appendix 4. - Recommendations for Grading of Acute and Subacute Toxicity ALLERGY

12 Dec 2012

View